Dr. Ondria Chris Gleason, MD

Dr. Gleason practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Gleason's NPI, 1255301651, was assigned on January 26, 2006. Dr. Gleason graduated from University of Nebraska College of Medicine in 1994. Dr. Gleason holds Oklahoma license 20626.

Dr. Gleason's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Gleason's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. The medical group on file is Central Oklahoma Community Mental Health Center. Dmand AI also links Dr. Gleason to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gleason practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Gleason's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Gleason is licensed in Oklahoma.

CMS data shows 131 Medicare services from Dr. Gleason across 3 procedure codes in 2024, for 77 Medicare patients. Medicare paid $10,560 for them.

CMS counts 77 Medicare patients who saw Dr. Gleason in 2024. The largest group is under 65, with 34 patients. 75% of them have anxiety, and 75% have depression. 55% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gleason's median patient age at 43, with 67% women.

In 2024, Dr. Gleason wrote 80 Medicare Part D claims for 14 patients. 98% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $21,091 in total drug cost. In 2022, CMS named 38 claims across 3 drugs.

Dr. Gleason accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gleason as offering telehealth.

Dmand AI links 9 papers to Dr. Gleason, published from 2013 to 2024. The most frequent topics are Hepatitis C, Depressive Disorder and Antidepressive Agents, Second-Generation. Dr. Gleason has published most often in Psychosomatics. Dr. Gleason's most frequent co-authors are Drew Samuel Dawson, MD, Douglas A. Drevets, MD and Wayne Curtis Drevets, MD.

CMS Open Payments shows 1 general payment to Dr. Gleason from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. LivaNova USA, Inc. paid the most, $13.

Dr. Gleason graduated from University of Nebraska College of Medicine in 1994.